Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Super-Resolution Imaging Technology Locates Specific DNA Sequences

By BiotechDaily International staff writers
Posted on 21 Oct 2013
Image: The super-resolution technique allows fluorescent-labeled probe DNA to pinpoint target DNA sequences in an immobilized strand in ways neither regular nor electron microscopes are able. The technique relies on multiple images of probes binding temporarily to targets as they flow over the strand and are captured by a camera (Photo courtesy of the Landes Group).
Image: The super-resolution technique allows fluorescent-labeled probe DNA to pinpoint target DNA sequences in an immobilized strand in ways neither regular nor electron microscopes are able. The technique relies on multiple images of probes binding temporarily to targets as they flow over the strand and are captured by a camera (Photo courtesy of the Landes Group).
With the use of advanced optical tools and sophisticated mathematics, researchers have found a way to target the location of specific sequences along single strands of DNA, a technique that could someday help diagnose genetic diseases.

Proof-of-concept research in the Rice University (Houston, TX, USA) lab of chemist Dr. Christy Landes identified DNA sequences as short as 50 nucleotides at room temperature, an achievement she noted is unfeasible with conventional microscopes that cannot see objects that tiny, or electron microscopes that require targets to be cryogenically frozen or in a vacuum.

The technique called super-localization microscopy has been known for a while, according to Dr. Landes, but its application in biosensing is in its early stages. Scientists have seen individual double-stranded DNA molecules under optical microscopes for a long time, but the ability to visualize single-stranded DNA is a new achievement, and breaking the diffraction limit of light adds value, she noted.

The study was published online September 27, 2013, in the American Chemical Society journal Applied Materials and Interfaces. The Rice researchers call their super-resolution technique motion blur point accumulation for imaging in nanoscale topography (mbPAINT). Using it, they resolved structures as small as 30 nm by making, fundamentally, a movie of fluorescent DNA probes flowing over a known target sequence along an immobilized single strand of DNA.

The probes are labeled with a fluorescent dye that lights up only when attached to the target DNA. In the experimental setup, most would flow by unseen, but some would bind to the target for a few milliseconds, just long enough to be captured by the camera before the moving liquid pulled them away. Processing images of these brief occurrences among the background blur allows the researchers to image objects smaller than the natural diffraction limits of light-based imaging, which do not allow for the resolution of targets smaller than the wavelength of light used to illuminate them.

Even the Dr. Landes lab’s system is subject to these physical boundaries. Individual images of fluorescing probes on targets are only a pixelated blur. However, it is a blur with a bright spot, and comprehensive analysis of multiple images allows the investigators to locate that spot along the strand.

Dr. Landes reported one objective for mbPAINT is to map minute fragments of DNA. “Eventually, we’d like to get down to a couple of nucleotides,” she said. “Some diseases are characterized by one amino acid mutation, which is three nucleotides, and there are many diseases associated with very small genetic mutations that we’d like to be able to identify. We’re thinking this method will be ideally suited for diseases associated with small, localized mutations that are not possible to detect in any other inexpensive way.”

Dr. Landes envisions mpPAINT as not only more cost-effective but also able to capture information electron microscopes cannot. “One of the reasons people invented electron microscopy is to image objects smaller than light’s diffraction limit, because biomolecules such as proteins and DNAs are smaller than that,” she said. “But electron microscopy requires cryogenic temperatures or a vacuum. You can’t easily watch things react in solution. The advent of this technology allows us to see the biological processes of nano-sized objects as they happen in water, with buffers and salts, at room temperature, at body temperature or even in a cell. It’s very exciting.”

Related Links:

Rice University



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.